Published in Med Toxicol on July 27, 1987
Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect (1998) 3.51
Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect (2006) 3.11
The Yugoslavia Prospective Study of environmental lead exposure. Environ Health Perspect (1999) 2.10
The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect (2006) 1.91
Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol (2008) 1.41
Lead and hypertension in a sample of middle-aged women. Am J Public Health (1999) 1.32
Neurohumoral blood pressure regulation in lead exposure. Environ Health Perspect (1988) 1.05
Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ Health Perspect (1988) 1.05
Effects of lead on vascular reactivity. Environ Health Perspect (1988) 1.03
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag (2011) 1.02
Associations among lead dose biomarkers, uric acid, and renal function in Korean lead workers. Environ Health Perspect (2005) 0.98
Chronic effects of lead on the renin-angiotensin system. Environ Health Perspect (1988) 0.97
Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect (1988) 0.92
Effects of low-level lead exposure on blood pressure and function of the rat isolated heart. Indian J Pharmacol (2008) 0.90
Two Welsh surveys of blood lead and blood pressure. Environ Health Perspect (1988) 0.81
Influence of membrane sodium transport upon the relation between blood lead and blood pressure in a general male population. Environ Health Perspect (1988) 0.79
Association of blood lead to blood pressure in men aged 55 to 75 years: effect of selected social and biochemical confounders. NFR Study Group. Environ Health Perspect (1994) 0.79
The effect of chelation on blood pressure in lead-exposed children: a randomized study. Environ Health Perspect (2006) 0.79
Effect of ascorbic acid supplementation on nitric oxide metabolites and systolic blood pressure in rats exposed to lead. Indian J Pharmacol (2010) 0.76
Low level exposure to lead. BMJ (1990) 0.75
Lead as a Risk Factor for Osteoporosis in Post-menopausal Women. Indian J Clin Biochem (2016) 0.75
Arsenic ingestion and internal cancers: a review. Am J Epidemiol (1992) 4.39
Diesel exhaust exposure and lung cancer. Epidemiology (1998) 4.08
Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol (1998) 4.07
Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology (1996) 3.49
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest (1996) 3.13
Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. Int J Epidemiol (1998) 2.92
Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect (1996) 2.83
Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J (Clin Res Ed) (1986) 2.75
Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence. JAMA (1994) 2.72
Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology (2000) 2.67
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke (2001) 2.60
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Amanita phalloides-type mushroom poisoning. West J Med (1982) 2.26
Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol (1995) 2.19
Environmental and biological monitoring for lead exposure in California workplaces. Am J Public Health (1990) 2.16
Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res (1993) 2.03
Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int J Epidemiol (2000) 2.03
Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation (1998) 2.00
Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation (1989) 1.93
Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology (1992) 1.90
Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med (2008) 1.82
Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect. J Exp Med (1975) 1.82
Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci U S A (1975) 1.76
Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev (1994) 1.71
De-functioning stomas: a prospective controlled trial comparing loop ileostomy with loop transverse colostomy. Br J Surg (1986) 1.71
Association of weight loss and weight fluctuation with mortality among Japanese American men. N Engl J Med (1995) 1.67
Consistent pattern of elevated symptoms in air-conditioned office buildings: a reanalysis of epidemiologic studies. Am J Public Health (1990) 1.66
A large 4 pi plastic scintillator-detector with clinical applications. Int J Appl Radiat Isot (1967) 1.62
Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev (1995) 1.60
Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst (1981) 1.52
Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health (1994) 1.52
Fatal anaphylaxis after intramuscular iron-dextran. Ann Intern Med (1966) 1.51
Non-Hodgkin's lymphoma and farming: an expanded case-control study. Int J Cancer (1987) 1.51
Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax (2000) 1.51
Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect (1996) 1.48
Social factors and minor psychiatric disorder in middle-aged men: a validation study and a population survey. Psychol Med (1991) 1.48
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res (2004) 1.48
Non-Hodgkin's lymphoma and exposure to phenoxyherbicides, chlorophenols, fencing work, and meat works employment: a case-control study. Br J Ind Med (1986) 1.46
Delayed health hazards of pesticide exposure. Annu Rev Public Health (1986) 1.45
Neurotoxicological evaluation of hospital sterilizer workers exposed to ethylene oxide. J Toxicol Clin Toxicol (1990) 1.43
Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am J Epidemiol (2006) 1.43
Effect of metoclopramide on gastric emptying during labour. Br Med J (1973) 1.42
Soft tissue sarcoma and exposure to phenoxyherbicides and chlorophenols in New Zealand. J Natl Cancer Inst (1984) 1.37
Phencyclidine poisoning. JAMA (1975) 1.37
Neuropsychologic "impairment" in a cohort of hospital workers chronically exposed to ethylene oxide. J Toxicol Clin Toxicol (1990) 1.37
Diagnosis and treatment of Amanita phalloides-type mushroom poisoning: use of thioctic acid. West J Med (1976) 1.36
Mortality and social class in New Zealand. I: overall male mortality. N Z Med J (1983) 1.36
Malignant lymphoma and multiple myeloma linked with agricultural occupations in a New Zealand Cancer Registry-based study. Am J Epidemiol (1985) 1.34
Observations on the dose-response curve for arsenic exposure and lung cancer. Scand J Work Environ Health (1993) 1.34
Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke (1996) 1.33
Serum retinol and the inverse relationship between serum cholesterol and cancer. Br Med J (Clin Res Ed) (1982) 1.33
Arsenic in drinking water and bladder cancer. Cancer Invest (2000) 1.32
Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res (1997) 1.31
Influence of Salts in the Diet on the Intestinal Flora of the Albino Rat. J Bacteriol (1937) 1.31
An examination of the relationship between fluoridation of water and cancer mortality in 20 large US cities. N Z Med J (1980) 1.31
The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis (1980) 1.31
Organophosphate polyneuropathy: pathogenesis and prevention. Neurology (1984) 1.27
Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol (2000) 1.21
Placebo-controlled double-blind trial of mianserin hydrochloride. Br J Clin Pharmacol (1978) 1.21
Sleep deprivation and house staff performance. Update 1984-1991. J Occup Med (1992) 1.19
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care (1999) 1.18
Case-control study of multiple myeloma and farming. Br J Cancer (1986) 1.18
Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes Care (1996) 1.18
Intraocular melanoma linked to occupations and chemical exposures. Epidemiology (1996) 1.17
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics (1999) 1.17
Use of medroxyprogesterone acetate as a contraceptive in conjunction with early postpartum rubella vaccination. Br Med J (1973) 1.16
Physical activity and incidence of diabetes: the Honolulu Heart Program. Am J Epidemiol (1995) 1.15
Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmos. JAMA (1968) 1.14
Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am J Ind Med (2001) 1.14
Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. Clin Nephrol (1979) 1.13
Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol (1996) 1.12
Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res (1998) 1.11
Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr (1992) 1.11
Cardiopulmonary catastrophes in drug-overdosed patients. Med Clin North Am (1979) 1.10
Long term changes in total body water, total exchangable sodium and total body potassium before and after ileostomy. Br J Surg (1975) 1.08
Environmental influences on helminthiasis and nutritional status among Pacific schoolchildren. Int J Environ Health Res (2004) 1.08
Factors associated with variations in pulmonary function among elderly Japanese-American men. Chest (1997) 1.08
Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med (1981) 1.08
Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev (1997) 1.08
A standardized benchmark approach to the use of cancer epidemiology data for risk assessment. Toxicol Ind Health (1985) 1.07
Mortality and social class in New Zealand II: male mortality by major disease groupings. N Z Med J (1983) 1.07
Congenital defects and miscarriages among New Zealand 2, 4, 5-T sprayers. Arch Environ Health (1982) 1.07
Changes in the Structure of the Developing Tooth in Rats Maintained on a Diet Deficient in Vitamin A. Yale J Biol Med (1941) 1.07
Dental Changes in Rats Consuming a Diet Poor in Inorganic Salts. Yale J Biol Med (1936) 1.06
Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation (1991) 1.05
Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium. J Toxicol Clin Toxicol (1982) 1.05
Ectopic gonadotropin production before clinical recognition of bronchogenic carcinoma. N Engl J Med (1968) 1.05
Cross-calibration of GE/Lunar pencil and fan-beam dual energy densitometers--bone mineral density and body composition studies. Eur J Clin Nutr (2003) 1.04
Distribution and correlates of lipids and lipoproteins in elderly Japanese-American men. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol (1996) 1.04
Use of unabsorbed radioactive marker substances in a re-assessment of the radioactive triolein test of fat absorption. J Clin Pathol (1971) 1.04
Social class, ethnic group, and male mortality in New Zealand, 1974-8. J Epidemiol Community Health (1985) 1.04
Cross-sectional neurotoxicology study of lead-exposed cohort. J Toxicol Clin Toxicol (1989) 1.03
Determinants of differences in mortality between New Zealand Maoris and non-Maoris aged 15-64. N Z Med J (1984) 1.03
Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. Circulation (1996) 1.03
Elevated blood pressure in treated hypertensives with low-level lead accumulation. Arch Environ Health (1989) 1.03
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men. Am J Cardiol (2000) 1.02
Relative weight, weight change, and risk of coronary heart disease in the Honolulu Heart Program. Am J Epidemiol (1998) 1.02